Tuscola, TX, United States of America

Oriana E Hawkins

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Oriana E. Hawkins: Advancing Breast Cancer Research through Patented Technologies

Introduction: Oriana E. Hawkins is a notable inventor based in Tuscola, Texas, recognized for her significant contributions to breast cancer research. With two patents to her name, her work focuses on identifying tumor-specific phosphorylated peptides that have the potential to revolutionize diagnostic methods and therapeutic approaches in oncology.

Latest Patents: Hawkins’ recent patents detail the identification of MHC class I phospho-peptide antigens from breast cancer using advanced SHLA technology and complementary enrichment strategies. These groundbreaking inventions describe novel tumor-specific phosphorylated peptides, along with the nucleic acids and antibodies generated against these peptides. The innovations presented in her patents have promising applications in diagnosing breast cancer and developing therapeutic strategies aimed at treating this prevalent disease.

Career Highlights: Throughout her career, Oriana E. Hawkins has been affiliated with prominent institutions. Notably, she has worked with Agenus Inc. and the University of Oklahoma, where she contributed to significant advancements in biomedical research. Her efforts in the field of cancer research position her as a key figure in the realm of medical innovation.

Collaborations: Hawkins has collaborated with esteemed professionals, including Donald F. Hunt and Andrew Norris, both of whom have contributed to her research endeavors. These partnerships have facilitated the development and enhancement of her patented technologies.

Conclusion: Oriana E. Hawkins exemplifies the spirit of innovation in the scientific community, particularly in the fight against breast cancer. Her patents not only highlight her inventive capabilities but also reflect her commitment to improving diagnostic and therapeutic options for patients battling this challenging disease. As researchers build on her work, the potential for new breakthroughs in cancer treatment remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…